Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study

Qual Life Res. 2021 Feb;30(2):465-466. doi: 10.1007/s11136-020-02720-1.
No abstract available

Publication types

  • Published Erratum